Prevalence of immunology testing in patients treated with alglucosidase alfa with significant hypersensitivity/anaphylactic reactions (ALGMYC07390)

03/08/2015
25/06/2024
EU PAS number:
EUPAS10526
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

rdct-ALGMYC07390_study protocol_V3_final 14dec2015_approved-PDFA

English (320.63 KB - PDF) View document
Study results
Study results

rdct-alglucosidase-alfa-PASS-immunology-testing_finalreport_abstract_FINAL 08 June 2020-PDFA

English (159.55 KB - PDF) View document
Study report
Other information